Skip to main content

Legal Update

California Becomes First State to Recognize Innovator Liability

26 January 2009
Mayer Brown Legal Update
On January 21, 2009, the California Supreme Court declined petitions to review the appellate court decision in Conte v. Wyeth, Inc., et al., 85 Cal. Rptr. 3d 299 (Cal. Ct. App. 2008). In Conte, the appellate court held that Wyeth, a name brand manufacturer of Reglan® (a prescription drug used to treat gastroesophageal reflux disease), has a duty to warn patients whose doctors allegedly rely on Wyeth's labeling information for name brand Reglan® when prescribing the drug, regardless of whether the patient's prescription is filled with the name brand drug or a generic version.


  • Henninger S. Bullock
    T +1 212 506 2528
  • Andrew J. Calica
    T +1 212 506 2256
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.